Modulation of synaptic plasticity by stress and antidepressants

Bipolar Disorders

Volumn 4, Issue 3, 2002, Pages 166-182

  Popoli, Maurizio ^a   Gennarelli, Massimo ^b   Racagni, Giorgio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Antidepressant; CaM kinase II; Glutamate; Long term potentiation; Mood disorders; NMDA receptor; Stress; Synaptic plasticity

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CITALOPRAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; GLUTAMIC ACID; HALOPERIDOL; IMIPRAMINE; KETAMINE; LEVOPROTILINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; OXAPROTILINE; PAROXETINE; PHENYTOIN; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

AFFECT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ATTENTION; BRAIN LEVEL; CELL SURVIVAL; CLINICAL STUDY; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; HUMAN; LIMBIC SYSTEM; MOUSE; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STRESS; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIDEPRESSIVE AGENTS; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; NEURONAL PLASTICITY; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 0036267726     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2002.01159.x     Document Type: Review

References (109)

1. Basic psychopharmacology of antidepressants, Part 1: Antidepressants have seven distinct mechanisms of action
2. Current advances and trends in the treatment of depression
3. Initiation and adaptation: A paradigm for understanding psychotropic drug action
4. Stress and hippocampal plasticity
5. Neuronal plasticity and survival in mood disorders
6. Subgenual prefrontal cortex abnormalities in mood disorders
7. Depression duration but not age predicts hippocampal Volume loss in women with recurrent major depression
8. The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review
9. Antidepressants for the new millennium
10. Serine/threonine kinases as molecular targets of antidepressants. Implications for pathophysiology and pharmacological treatment
11. The Organization of Behavior
12. A synaptic model of memory: Long-term potentiation in the hippocampus
13. Long-term potentiation - A decade of progress?
14. Synaptic plasticity and memory: An evaluation of the hypothesis
15. Postsynaptic protein phosphorylation and LTP
16. The multifunctional calcium/calmodulin-dependent protein kinase: From form to function
17. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM kinase II during long-term potentiation
18. 286 of the αcalcium-calmodulin kinase II in LTP and learning
19. Driving AMPA receptors into synapses by LTP and CaMKII. Requirement for GluR1 and PDZ domain interaction
20. 2+/calmodulin-dependent protein kinase II
21. 2+/calmodulin-dependent protein kinase II in intact nerve terminals
22. Synapsins as regulators of neurotransmitter release
23. 2+/calmodulin protein kinase II in synaptic vesicles
24. Regulation of synaptotagmin I phosphorylation by multiple protein kinases
25. Calcium/calmodulin-dependent protein kinase II increases glutamate and noradrenaline release from synaptosomes
26. 2+ -calmodulin-dependent protein kinase II of the transmitter release in squid giant synapse
27. Silent synapses: I can't hear you! Could you please speak aloud?
28. Cyclic AMP induces functional presynaptic boutons in hippocampal CA3-CA1 neuronal cultures
29. 2+/calmodulin-dependent protein kinase II and its endogenous substrates in the induction of long-term potentiation
30. 2+/calmodulin-dependent protein kinase II phosphorylation of the presynaptic protein synapsin I is persistently increased during long-term potentiation
31. Behavioral stress impairs long-term potentiation in rodent hippocampus
32. Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus
33. Synaptic efficacy in the entorhinal-dentate pathway and stress ulcers in rats
34. Granul cell potentials in the dentate gyrus of the hippocampus: Coping behaviour and stress ulcers in rats
35. Behavioral stress modifies hippocampal plasticity through N-methyl-D-aspartate receptor activation
36. Behavioural stress facilitates the induction of long-term depression in the hippocampus
37. Glucocorticoid receptor and protein/RNA synthesis-dependent mechanisms underlie the control of synaptic plasticity by stress
38. A million dollar question: Does LTP = memory?
39. The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments
40. The Neuropsychology of Anxiety: An Enquiry Into the Functions of the Septo-Hippocampal System
41. Two-stage model of memory trace formation: A role for 'noisy' brain states
42. Restoration of decaying long-term potentiation in the hippocampal formation by stimulation of neuromodulatory nuclei in freely moving rats
43. LTP-like synaptic efficacy changes following electroconvulsive stimulation
44. Impaired spatial learning after saturation of long-term potentiation
45. Acute effects of antidepressant drugs on long-term potentiation (LTP) in rat hippocampal slices
46. Use-dependent effects of acute and chronic treatment with imipramine and buspirone on excitatory synaptic transmission in the rat hippocampus
47. Chronic effects of triimipramine, an antidepressant, on hippocampal synaptic plasticity
48. Repeated ECS and fluoxetine administration have equivalent effects on hiippocampal synaptic plasticity
49. How antidepressants work
50. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression
51. Chronic stress alters synaptic terminal structure in hippocampus
52. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus
53. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
54. Impairments in high frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice
55. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses
56. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid
57. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatment
58. Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain
59. Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells
60. Brain derived neurotrophic factor induction of N-methyl-D-aspartate receptor subunit NR2A expression in cultured rat cortical neurons
61. Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity
62. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus
63. Brain-derived neurotrophic factor increases the stimulation-evoked release of glutamate and the levels of exocytosis-associated proteins in cultured cortical neurons from embryonic rats
64. Neurotrophins modulation of NMDA receptors in cultured murine and isolated rat neurons
65. Ischemia-induced neuronal damage: A role for calcium/calmodulin-dependent protein kinase II
66. 2+/calmodulin-dependent protein kinase II in cultured rat hippocampal neurons
67. 2+/calmodulin-dependent protein kinase II associated with an endoplasmic reticulum stress response in vascular smooth muscle
68. Stress: Metaplastic effects in the hippocampus
69. Increased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine
70. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine
71. 2+/calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: Differential regulation of α and β isoforms
72. Increased calcium/calmodulin protein kinase activity in astrocytes chronically exposed to ethanol. influences on glutamate transport
73. 2+/calmodulin-dependent protein kinase II. autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake
74. Synaptotagmin phosphorylation is affected by long-term blockade of 5-HT reuptake
75. Modification of presynaptic CaM kinase II affinity for ATP in hippocampus after long term blockade of serotonin reuptake
76. The effect of prolonged imipramine and electroconvulsive shock treatment on calcium/calmodulin-dependent protein kinase II in the hippocampus of rat brain
77. Effects of imipramine and sertraline on protein kinase activity in rat frontal cortex
78. Protein phosphorylation and the regulation of synaptic membrane traffic
79. Modifications in brain CaM kinase II after long-term treatment with desmethylimipramine
80. 2+ sensor for transmitter release at a central synapse
81. 2+ and assembly with the core SNARE complex onto membranes
82. Calcium dependence of neurotransmitter release and rate of spontaneous vesicle fusions are altered in Drosophila synaptotagmin mutants
83. Changes of synaptotagmin interaction with t-SNARE proteins in vitro after calcium/calmodulin-dependent phosphorylation
84. Phosphorylation of the synaptic protein interaction site on N-type calcium channels inhibits interactions with SNARE proteins
85. A molecular approach to the calcium signal in brain relationship to synaptic modulation and seizure discharge
86. Neuroplasticity and cellular resilience in mood disorders
87. mRNA localization in neurons: A multipurpose mechanism?
88. 2+/calmodulin-dependent protein kinase II via dendritic protein synthesis in hippocampal neurons
89. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytriptamine measured in vivo
90. An analysis of the effects of acute and chronic fluoxetine on extracellular norepinephrine in the rat hippocampus during stress
91. Acute application of the tricyclic antidepressant desipramine presynaptically stimulates the exocytosis of glutamate in the hippocampus
92. Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex. A possible mechanism of neuroprotection in major depression
93. GABA function in mood disorders an update and critical review
94. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice
95. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning
96. Neurotrophins as synaptic modulators
97. Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons
98. Neurotrophin expression in rat hippocampal slices: A stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs
99. The relationship between neuronal survival and regeneration
100. Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons
101. Gating of BDNF-induced synaptic potentiation by cAMP
102. Ultrastructural localization of full-length trkB immunoreactivity in rat hippocampus suggests multiple roles in modulating activity-dependent synaptic plasticity
103. Synapsins as mediators of BDNF-enhanced neurotransmitter release
104. 2+/calmodulin-dependent protein kinase 2 activity in hippocampus
105. 2+/Calmodulin-dependent protein kinase II and mitogen-activated protein kinase activation in hippocampal long-term potentiation
106. BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses
107. Long-term enhancement of central synaptic transmission by chronic brain-derived neurotrophic factor treatment
108. Brain-derived neurotrophic factor differentially regulates excitatory and inhibitory synaptic transmission in hippocampal cultures
109. Neurotrophins induce formation of functional excitatory and inhibitory synapses between cultured hippocampal neurons